UnitedHealth Group Inc (UNH) Holdings Boosted by ACG Wealth
ACG Wealth grew its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,467 shares of the healthcare conglomerate’s stock after purchasing an additional 540 shares during the period. ACG Wealth’s holdings in UnitedHealth Group were worth $4,596,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Putnam FL Investment Management Co. acquired a new stake in shares of UnitedHealth Group in the 3rd quarter worth approximately $14,816,000. IBM Retirement Fund grew its holdings in shares of UnitedHealth Group by 1.3% in the 3rd quarter. IBM Retirement Fund now owns 23,774 shares of the healthcare conglomerate’s stock worth $5,124,000 after acquiring an additional 296 shares during the period. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of UnitedHealth Group by 8.6% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 31,926 shares of the healthcare conglomerate’s stock worth $6,253,000 after acquiring an additional 2,534 shares during the period. Cambridge Investment Research Advisors Inc. grew its holdings in shares of UnitedHealth Group by 2.4% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 54,850 shares of the healthcare conglomerate’s stock worth $10,742,000 after acquiring an additional 1,301 shares during the period. Finally, Russell Investments Group Ltd. grew its holdings in shares of UnitedHealth Group by 3.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 2,205,164 shares of the healthcare conglomerate’s stock worth $431,822,000 after acquiring an additional 72,946 shares during the period. Institutional investors own 86.09% of the company’s stock.
In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares in the company, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. In the last three months, insiders have sold 34,630 shares of company stock worth $7,669,416. Corporate insiders own 0.89% of the company’s stock.
A number of equities research analysts recently weighed in on UNH shares. Cantor Fitzgerald upped their price target on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Wells Fargo & Co restated an “outperform” rating and issued a $245.00 price target (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Credit Suisse Group started coverage on UnitedHealth Group in a report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price target on the stock. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Finally, Royal Bank of Canada upped their price target on UnitedHealth Group to $244.00 and gave the stock an “outperform” rating in a report on Wednesday, November 29th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $230.22.
Shares of UnitedHealth Group Inc (NYSE:UNH) opened at $232.90 on Wednesday. UnitedHealth Group Inc has a 52 week low of $156.09 and a 52 week high of $235.00. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $225,180.00, a P/E ratio of 26.47, a P/E/G ratio of 1.54 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same quarter in the prior year, the company posted $2.11 EPS. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. equities analysts forecast that UnitedHealth Group Inc will post 9.99 earnings per share for the current year.
WARNING: This piece was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://www.watchlistnews.com/unitedhealth-group-inc-unh-holdings-boosted-by-acg-wealth/1810126.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with Analyst Ratings Network's FREE daily email newsletter.